Fig. 1From: Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM developmentOverall survival of PLWHA receiving anti-retroviral therapy by cancer status from time of a cancer diagnosis and b start of antiretroviral therapyBack to article page